Editing Phosphodiesterase inhibitor (section)

===PDE3 selective inhibitors===
{{Main|PDE3 inhibitor}}
*[[Amrinone]], [[milrinone]] and [[enoximone]] are used clinically for short-term treatment of [[cardiac failure]].  These drugs mimic [[sympathetic nervous system|sympathetic]] stimulation and increase [[cardiac output]].
*[[Anagrelide]]<ref>{{cite journal | pmc = 2983030 | pmid=21120194 | doi=10.5045/kjh.2010.45.2.136 | volume=45 | issue=2 | title=Development of acute myocardial infarction in a young female patient with essential thrombocythemia treated with anagrelide: a case report | year=2010 | journal=Korean J Hematol | pages=136–8 |vauthors=Lim YH, Lee YY, Kim JH, Shin J, Lee JU, Kim KS, Kim SK, Kim JH, Lim HK }}</ref>
*[[Cilostazol]] is used in the treatment of [[intermittent claudication]].
*[[Pimobendan]] is FDA approved for veterinary use in the treatment of heart failure in animals.

[[PDE3]] is sometimes referred to as cGMP-inhibited phosphodiesterase.